Composition for improving proliferative response during adapation of gastrointestinal tract and use in short bowel syndrome
A syndromic, short-bowel technology applied to formulations containing long-chain polyunsaturated fatty acids, able to resolve issues such as lack of statistical significance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment
[0020]Infant formulas suitable for use in the present invention are listed below:
[0021] Formula A
[0022] components gram %
[0023] Water 48.5 82.5
[0024] Maltodextrin 7.1 10.6
[0025] Sodium and calcium caseinate 1.6 2.4
[0026] Whey Protein Concentrate 2.6 3.9
[0027] Vegetable oil 6.0 9.0
[0028] Minerals 0.25 0.37
[0029] Vitamin 0.02 0.03
[0030] 66.0 100
[0031] The caloric distribution of formula A is about 28.4% CHO, 16.8% protein and 54.8% fat; 150 kcal / 100cc.
[0032] Listed below are various fat blends which are used to optimize the delivery of the high levels of eicosatetraenoic acid and docosahexaenoic acid necessary in the formulations of the present invention. The formulations of fat blends 1-3 contained different concentrations of arachidonic acid and docosahexaenoic acid, which met the GRAS regulations of the US Food and Drug Administration for the administration of ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com